Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SEEL

Seelos Therapeutics (SEEL) Stock Price, News & Analysis

Seelos Therapeutics logo

About Seelos Therapeutics Stock (NASDAQ:SEEL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2 shs
Average Volume
174,745 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SEEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Seelos Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SEEL Stock News Headlines

Seelos Therapeutics Stock Price History
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
Seelos Therapeutics, Inc. (SEELQ)
Seelos Therapeutics Inc SEELQ
See More Headlines

SEEL Stock Analysis - Frequently Asked Questions

Seelos Therapeutics shares reverse split on the morning of Friday, September 27th 2024.The 1-16 reverse split was announced on Wednesday, September 25th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Seelos Therapeutics investors own include Digital Turbine (APPS), Okta (OKTA), CrowdStrike (CRWD), SoFi Technologies (SOFI) and ChargePoint (CHPT).

Company Calendar

Today
7/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SEEL
CIK
1017491
Employees
20
Year Founded
2016

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$37.88 million
Net Margins
203.13%
Pretax Margin
203.13%
Return on Equity
N/A
Return on Assets
-431.47%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.08
Quick Ratio
0.08

Sales & Book Value

Annual Sales
$2.20 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($437.92) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
372,000
Free Float
368,000
Market Cap
N/A
Optionable
Optionable
Beta
1.94

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:SEEL) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners